Overview A Phase 3 Clinical Study of QLM3004 in Delaying Myopia in Children Status: Recruiting Trial end date: 2027-06-01 Target enrollment: Participant gender: Summary Efficacy and Safety Study of QLM3004 in Myopic Children Phase: Phase 3 Details Lead Sponsor: Qilu Pharmaceutical Co., Ltd.